Clinicopathological Features and Prognosis of Hepatic Epithelioid Hemangioendothelioma After Liver Resection and Transplantation-Reference-Cited by-同舟云学术

Clinicopathological Features and Prognosis of Hepatic Epithelioid Hemangioendothelioma After Liver Resection and Transplantation

Published:2016-12-29 Issue: Volume:21 Page:784-790
ISSN:2329-0358
Container-title:Annals of Transplantation
language:en
Short-container-title:Ann Transplant

Author:

Jung Dong-Hwan¹,Hwang Shin¹,Hong Seung-Mo²,Kim Ki-Hun¹,Lee Young-Joo¹,Ahn Chul-Soo¹,Moon Deok-Bog¹,Ha Tae-Yong¹,Song Gi-Won¹,Park Gil-Chun¹,Yu Eunsil²,Lee Sung-Gyu¹

Affiliation:

1. Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

2. Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Publisher

International Scientific Information, Inc.

Subject

Transplantation,General Medicine

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-term outcomes of combined therapy with sirolimus and interferon-alpha 2b for advanced hepatic epithelioid hemangioendothelioma;Therapeutic Advances in Medical Oncology;2024-01

2. Hepatic epithelioid hemangioendothelioma—a single-institution experience with 51 cases;Frontiers in Oncology;2023-08-03

3. The challenging surgical management of hepatic epithelioid hemangioendothelioma: a narrative review;Chinese Clinical Oncology;2022-08

4. Novel and Specific MRI Features Indicate the Clinical Features of Patients With Rare Hepatic Tumor Epithelioid Hemangioendothelioma;Frontiers in Oncology;2022-01-27

5. Advanced epithelioid hemangioendothelioma of the liver: could lenvatinib offer a bridge treatment to liver transplantation?;Therapeutic Advances in Medical Oncology;2022-01